Paper 68 - NCOR1 IS AMPLIFIED IN LEIOMYOSARCOMA AND OSTEOSARCOMA WHERE ITS EXPRESSION LEVELS ARE ASSOCIATED WITH DISTINCT TRANSCRIPTIONAL STATES

Author(s)

• 

  Julia Leix, MD

  PGY-VI Pediatric Hematology/Oncology Fellow
  University of Pittsburgh/UPMC Children's Hospital of Pittsburgh
  Pittsburgh, Pennsylvania, United States

Co-Author(s)

• MZ

  Megan Zilla, M.D. PhD

  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania, United States
• LZ

  Lucas Zheng, BS

  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• ZW

  Ziyang Wang, MS (he/him/his)

  Bioinformatician
  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• SW

  Shuaichao Wang, PhD

  UPMC Hillman Cancer Center, Biostatistical Facility
  Pittsburgh, Pennsylvania, United States
• ST

  Sagarika Tiwari, MS

  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• BR

  Brittany Royes, MS

  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• 

  Tanya Heim, BS, MS

  Lab Manager
  UPMC Hillman Cancer Center
  Pittsburgh, Pennsylvania, United States
• AS

  Aatur Singhi, MD, PhD

  Associate Professor
  University of Pittsburgh, Department of Pathology
  Pittsburgh, Pennsylvania, United States
• IJ

  Ivy John, MD

  Division Director, Bone and Soft Tissue Pathology, Associate Professor of Pathology
  University of Pittsburgh, Department of Pathology
  Pittsburgh, Pennsylvania, United States
• 

  Kurt Weiss, MD (he/him/his)

  Associate Professor and Advisory Dean
  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania, United States
• 

  Benjamin A. Nacev, MD, PhD

  Assistant Professor
  University of Pittsburgh Hillman Cancer Center
  Pittsburgh, Pennsylvania, United States